Moderna cancer vaccine results confirm efficacy; AI's lifecycle in drug development
anshulkundaje · x · 2026-08-20
Moderna and Merck's cancer vaccine confirmed Phase 2 results in a late-stage melanoma trial. The author discusses the lifecycle of AI in drug development, distinguishing between 'boring' legacy ML techniques embedded in diagnostics and the 'hypey' frontier areas like virtual cells.
Related event: Moderna's AI-Driven Personalized mRNA Cancer Therapy Succeeds in Phase 3(4 posts)→
More from Companies & People
- Every's new Frontier Team turns weird AI experiments into products weekly — every · 2026-08-20
- Yoav: It's legit to admit non-scholarly factors in academic appointments — yoavgo · 2026-08-20
- Yoav Goldberg: If this work is median, the field is in trouble — yoavgo · 2026-08-20
- German Cognitive Science Program Hiring Full Professor — TimKietzmann · 2026-08-20
- Trump tries ChatGPT, aide says it already boosted his work — rohanpaul_ai · 2026-08-20
- Cambridge controversy: Yoav questions appointment based on non-scholarly factors — asayeed · 2026-08-20